| |
|
|
|
Oxford Global, Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, W6 8DR, London, UK
27 - 29 April 2020
- Over 450 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.
- Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing.
View Agenda: https://bit.ly/2MU7dBq
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
Tristan Vaughan, Vice President R&D, Antibody Discovery & Protein Engineering, AstraZeneca
Stanislas Blein, Vice President, Head of Antibody Engineering, Glenmark Pharmaceuticals
John McCafferty, Chief Executive Officer, IONTAS Pharmaceuticals
For the full list of speakers, please see the agenda: https://bit.ly/2qR7TPu
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
https://bit.ly/369yLKG
|
|
|
E-mail:
|
|
d.dalby@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|